Clinical and pathophysiological characteristics of valproate-induced pleural effusion

References

• Bialer M. Why are antiepileptic drugs used for nonepileptic conditions? Epilepsia. 2012;53:26–33.
   PubMed Web of Science ®Google Scholar
• Aluisio AR, Zehtabchi S. Valproate for adult migraine prophylaxis. Am Fam Physician. 2016;94(9):727b.
   PubMed Web of Science ®Google Scholar
• Tan J, Cang S, Ma Y, et al. Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol. 2010;3:5.
   PubMed Web of Science ®Google Scholar
• Methaneethorn J. A systematic review of population pharmacokinetics of valproic acid. Br J Clin Pharmacol. 2018;84(5):816–834.
   PubMed Web of Science ®Google Scholar
• Nau H, Löscher W. Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse. J Pharmacol Exp Ther. 1982;220(3):654–659.
   PubMed Web of Science ®Google Scholar
• Vlahopoulos D, Saroglou M, Aggelis N, et al. Differences Between the Two Types of Pleural Effusion Related to Taking Valproic Acid; Unknown Origin pleuritis versus drug induced lupus pleural effusion. Chest. 2015;148(4):424A.
   Web of Science ®Google Scholar
• Tryfon S, Saroglou M, Kazanas K, et al. Sodium valproate as a cause of recurrent transudative pleural effusion: a case report. J Med Case Reports. 2009;3(1):51.
   PubMedGoogle Scholar
• Papadopoulou E, Tryfon S, Saroglou M, et al. valproic acid induced pleural effusion: a rare clinical and pathophysiological entity. Int J Clin Res Trials. 2020;5(2):150.
   Google Scholar
• Vlachopoulos D, Fouka E, Parisis C, et al. A case of drug induced lupus erythematosus after combined treatment with sodium valproate and risperidone. Pneumon. 2012;25(4):436–439.
   Google Scholar
• Kravetz JD, Federman DG. Valproic acid-induced eosinophilic pleural effusion. South Med J. 2003;96(8):803–806.
   PubMed Web of Science ®Google Scholar
• Baker S, Malik R. Valproic acid associated pleural effusion. Am J Respir Crit Care Med. 2019;199:A6263.
   Google Scholar
• Shaib FH, Patel B. A case of eosinophilic pleural effusion secondary to valproic acid. Chest. 2000;118(4):308S.
   Google Scholar
• Zhang G. Valproic acid-induced eosinophilic pleural effusion: a case report and brief review. Ann Clin Psychiatry. 2020;32(4):288–290.
   PubMed Web of Science ®Google Scholar
• Kaufman J, O’Shaughnessy IM. Eosinophilic pleural effusion associated with valproic acid administration. South Med J. 1995;88(8):881–882.
   PubMed Web of Science ®Google Scholar
• Savvas SP, Dimopoulou E, Koskinas J. Valproic acid-associated eosinophilic pleural effusion treated with corticosteroids. Eur J Intern Med. 2006;17(1):71.
   PubMed Web of Science ®Google Scholar
• Catalán Alcántara A, Sánchez Pérez M, Domezain del Campo M, et al. Eosinophilic pleural effusion secondary to treatment with valproic acid. Actas Esp Psiquiatr. 2005;33(6):401–402.
   PubMed Web of Science ®Google Scholar
• Bullington W, Sahn SA, Judson MA. Valproic acid-induced eosinophilic pleural effusion: a case report and review of the literature. Am J Med Sci. 2007;333(5):290–292.
   PubMed Web of Science ®Google Scholar
• Fernández-Pérez R, Alvarez-Dobaño JM, Suárez-Antelo J, et al. Eosinophilic pleural effusion associated with the addition of sodium valproate. J Clin Psychopharmacol. 2009;29(3):310–311.
   PubMed Web of Science ®Google Scholar
• Joshi P, Kasmani R, Hollingsworth J, et al. Divalproex sodium-induced eosinophilic pleural effusion. Am J Ther. 2009;16(6):593–595.
   PubMed Web of Science ®Google Scholar
• Kamenetsky Z, Da’as N, Esayag Y, et al. Valproic acid-induced eosinophilic pleural effusion: a case report and review of the literature. Neurologist. 2012;18(1):39–40.
   PubMed Web of Science ®Google Scholar
• Vasilescu R. Pleurezie eozinofilică de cauză medicamentoasă. Pneumologia. 2014;63(2):118–121.
   PubMedGoogle Scholar
• Aral A, Usta MB, Karabekiroglu K. Valproic acid-induced eosinophilic pleural effusion in a patient with pediatric bipolar disorder. Asia Pac Psychiatry. 2017;9(3):e12276.
   Web of Science ®Google Scholar
• André S, Drowart A, De Bels D. Lymphocytic pleural effusion associated with valproic acid. Eur J Intern Med. 2005;16(7):535.
   PubMedGoogle Scholar
• Joshi S, Gupta R, Bhatia A. Unusual case of pleural effusion – not everything is tuberculosis. EC Pulmonol Respir Med. 2018;7(10):741–743.
   Google Scholar
• Taşer N, Sarıkaya M. An unusual case of pleuropericardial neutrophilic effusion associated with valproate. J Formos Med Assoc. 2015;114(4):375–376.
   PubMed Web of Science ®Google Scholar
• Demir UF. Valproic acid associated pleuropericardial effusion: case report. Ideggyogy Sz. 2020;73(1–2):70–72.
   PubMedGoogle Scholar
• Bally C, Martin C, Kraoua S, et al. Une pleurésie à éosinophiles liée à la prise d'acide valproïque. Rev Pneumol Clin. 2011;67(6):366–367.
   Web of Science ®Google Scholar
• Boussaadani Soubai R, Lahloub M, Tahiria L, et al. Valproate-induced systemic lupus erythematous: a case report. Rev Neurol. 2013;169(3):275–281.
   PubMed Web of Science ®Google Scholar
• Tonnelier JM, Mocquard Y, Broch C, et al. Febrile pleuropericarditis during valproic acid treatment. Presse Med. 2001;30(2):62–63.
   PubMed Web of Science ®Google Scholar
• Chiles C, van Wattum PJ. Pleural fluid eosinophilia with combined pharmacotherapy. Psychosomatics. 2003;44(5):436–437.
   PubMed Web of Science ®Google Scholar
• Inanli I, Etli T, Ozturk HI, et al. Pericardial and pleural effusion with valproic acid use in a patient with bipolar disorder. Bulletin Clin Psychopharmacol. 2014;24(4):387–390.
   Web of Science ®Google Scholar
• López de Uraldea SMS, Peraitab MP, Bengoecheac EJB. Pulmonary eosinophilia associated with valproic acid. Med Clin. 2015;144(11):527–528.
   PubMed Web of Science ®Google Scholar
• Abdelhamid MS, Percival M, Sivakumaran P. Sodium valproate – a rare cause of eosinophilic pleural effusion. Intern Med J. 2011;41(11):802–803.
   PubMed Web of Science ®Google Scholar
• Darban M, Bagheri B. Drug reaction with eosinophilia and systemic symptoms induced by valproic acid: a case report. Iran Red Crescent Med J. 2016;18(9):e36825.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Ozaki T, Kamei T, et al. Factors that stimulate the proliferation and survival of eosinophils in eosinophilic pleural effusion: relationship to granulocyte/macrophage colony-stimulating factor, interleukin-5, and interleukin-3. Am J Respir Cell Mol Biol. 1993;8(6):605–611.
   PubMed Web of Science ®Google Scholar
• Katayama H, Yokoyama A, Kohno N, et al. Production of eosinophilic chemokines by normal pleural mesothelial cells. Am J Respir Cell Mol Biol. 2002;26(4):398–403.
   PubMed Web of Science ®Google Scholar
• Kalomenidis I, Light RW. Pathogenesis of the eosinophilic pleural effusions. Curr Opin Pulm Med. 2004;10(4):289–293.
   PubMed Web of Science ®Google Scholar
• Gesser B, Lund M, Lohse N, et al. IL-8 induces T cell chemotaxis, suppresses IL-4, and up-regulates IL-8 production by CD4+ T cells. J Leukoc Biol. 1996;59(3):407–411.
   PubMed Web of Science ®Google Scholar
• Qin XJ, Shi HZ, Huang ZX, et al. Interleukin-16 in tuberculous and malignant pleural effusions. Eur Respir J. 2005;25(4):605–611.
   PubMed Web of Science ®Google Scholar
• Qin XJ, Shi HZ, Deng JM, et al. CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clin Cancer Res. 2009;15(7):2231–2237.
   PubMed Web of Science ®Google Scholar
• Wu C, Zhou Q, Qin XJ, et al. CCL22 is involved in the recruitment of CD4 + CD25 high T cells into tuberculous pleural effusions. Respirology. 2010;15(3):522–529.
   PubMed Web of Science ®Google Scholar
• Kroegel C, Antony VB. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J. 1997;10(10):2411–2418.
   PubMed Web of Science ®Google Scholar